Miami, FL, April 18, 2018 -- VITAS® Healthcare, the nation’s leading provider of end-of-life care, will be a contributing sponsor for the America’s Physician Groups national conference, “Taking Responsibility for America’s Health,” held April 19-21, 2018 at the Manchester Grand Hyatt in San Diego.
|
|||
At the conference, VITAS will meet with physician group leaders and independent practice associations to demonstrate the value of hospice and palliative care for their practices. Consistent with the focus of the APG event, VITAS works with patients’ physicians to deliver high-quality care that is also cost-effective— two key factors that define value-based care in today’s healthcare environment.
“Shifting to risk-based care can be daunting for physicians and physician groups. VITAS has 40 years of experience and results in caring for complex, seriously ill patients under capitated, coordinated care models,” says Dr. Alen Voskanian, MD, MBA, VITAS Regional Medical Director for California and a 2017 member of the Health Innovators Fellowship sponsored by the Aspen Institute Global Leadership Network.
"When high- and rising-risk patients can be where they want to be near the end of life, quality rises and costs fall,” he points out. “A VITAS partnership brings an interdisciplinary team, mobile-first technology and care planning strategies that help physicians mitigate risks, reduce costs and improve quality across the continuum of care—key elements of success in today’s healthcare delivery system.”
VITAS representatives will be available at Exhibit Booth 319 during the April 20 Exhibit Fair. Joining Dr. Voskanian at APG will be VITAS medical directors Michael Nisco, MD of San Francisco and Chalat Rajaram, MD of Orange County. In March, Dr. Nisco was named a 2018 Visionary Leader by the American Academy of Hospice and Palliative Medicine.
About VITAS Healthcare
VITAS® Healthcare, a pioneer and leader in the hospice movement since 1978, is the nation’s leading provider of end-of-life care. Headquartered in Miami, Florida, VITAS (pronounced VEE-tahs) operates 44 hospice programs in 14 states (California, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin) and the District of Columbia. VITAS employs 11,627 professionals who care for terminally ill patients daily, primarily in the patients’ homes, but also in the company’s 27 inpatient hospice units as well as in hospitals, nursing homes and assisted living communities/residential care facilities for the elderly. At the conclusion of the fourth quarter of 2017, VITAS reported an average daily census of 16,976. Visit www.vitas.com.
Claudia Quintana VITAS Healthcare 877-848-2701 [email protected]


Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
World game at war: why some European nations have threatened a World Cup boycott
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 



